JohnMendelsohnMD

PubMed

• 2 citations
  Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory (Oncotarget (2017) 8 (41806-41814) D...
  Natalia Paez Arango, Lauren Brusco, Kenna R. Mills Shaw, Ken Chen, Agda Karina Eterovic, Vijaykumar Holla, Amber Johnson, Beate C. Litzenburger, Yekaterina B. Khotskay...> ;Oncotarget. 2019 Jan 1
• 299 citations
  Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.
  Jordi Rodon, Jean-Charles Soria, Raanan Berger, Wilson H. Miller, Eitan Rubin, Aleksandra Kugel, Apostolia Maria Tsimberidou, Pierre Saintigny, Aliza Ackerstein, Irene...> ;Nature Medicine. 2019 Apr 22
• 11 citations
  Expanded Analysis of Secondary Germline Findings From Matched Tumor/Normal Sequencing Identifies Additional Clinically Significant Mutations
  Ecaterina Ileana Dumbrava, Lauren Brusco, Molly S. Daniels, Chetna Wathoo, Kenna R. Shaw, Karen H. Lu, Xiaofeng Zheng, Louise C. Strong, Jennifer K. Litton, Banu Arun,...> ;JCO Precision Oncology. 2019 Apr 11
• 8 citations
  Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer
  Shuying Liu, Shunqiang Li, Bailiang Wang, Wenbin Liu, Mihai Gagea, Huiqin Chen, Joohyuk Sohn, Napa Parinyanitikul, Tina Primeau, Kim Anh Do, George F. Vande Woude, Joh...> ;Molecular Cancer Therapeutics. 2019 Feb 1
• 41 citations
  Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer
  Funda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, Senthil Damodaran, Chetna Wathoo, Lauren Brusco, Mehmet Esat Demirhan, Coya Tapia, Agda Karina Eterovic, Reva K....> ;JCO Precision Oncology. 2018 Apr 25
• 10 citations
  Physician interpretation of genomic test results and treatment selection.
  Lauren Brusco, Chetna Wathoo, Kenna R. Mills Shaw, Vijaykumar Holla, Ann Marie Bailey, Amber Johnson, Yekaterina B. Khotskaya, Beate C. Litzenburger, Nora S. Sanchez, ...> ;Cancer. 2018 Mar 1
• 22 citations
  "Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.
  Katherine C. Kurnit, Ann M. Bailey, Jia Zeng, Amber Johnson, Md. Abu Shufean, Lauren Brusco, Beate C. Litzenburger, Nora S. Sanchez, Yekaterina B. Khotskaya, Vijaykuma...> ;Cancer Research. 2017 Nov 1
• 23 citations
  Clinical Use of Precision Oncology Decision Support
  Amber Johnson, Yekaterina B. Khotskaya, Lauren Brusco, Jia Zeng, Vijaykumar Holla, Ann Marie Bailey, Beate C. Litzenburger, Nora S. Sanchez, Abu Shufean, Sarina Anne P...> ;JCO Precision Oncology. 2017 Sep 13
• 110 citations
  Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study
  Apostolia-Maria Tsimberidou, David S. Hong, Yang Ye, Carrie Cartwright, Jennifer J. Wheler, Gerald S. Falchook, Aung Naing, Siqing Fu, Sarina Anne Piha-Paul, Filip Jan...> ;JCO Precision Oncology. 2017 Sep 8
• 39 citations
  Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
  Katherine C. Kurnit, Ecaterina Ileana Dumbrava, Beate C. Litzenburger, Yekaterina B. Khotskaya, Amber Johnson, Timothy A. Yap, Jordi Rodon, Jia Zeng, Abu Shufean, Ann ...> ;Clinical Cancer Research. 2018 Jun 15
• 3 citations
  A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory.
  Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, Ken Chen, Agda Karina Eterovic, Vijaykumar Holla, Amber Johnson, Beate Litzenburger, Yekaterina B Khotskaya, No...> ;Oncotarget. 2017 Jun 27
• 105 citations
  ALK: a tyrosine kinase target for cancer therapy.
  Vijaykumar Holla, Yasir Elamin, Ann Marie Bailey, Amber Johnson, Beate C. Litzenburger, Yekaterina B. Khotskaya, Nora S. Sanchez, Jia Zeng, Abu Shufean, Kenna R. Shaw,...> ;Cold Spring Harbor Molecular Case Studies. 2017 Jan 1
• 3 citations
  Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and Outcomes
  Molly S. Daniels, Chetna Wathoo, Lauren Brusco, Karen H. Lu, Kenna R. Mills Shaw, Ecaterina Ileana Dumbrava, Banu Arun, Louise C. Strong, Jennifer K. Litton, Karina Et...> ;JCO Precision Oncology. 2017 Oct 31
• 19 citations
  Clinical outcomes based on multigene profiling in metastatic breast cancer patients
  Reva K. Basho, Debora de Melo Gagliato, Naoto T. Ueno, Chetna Wathoo, Huiqin Chen, Maryam Shariati, Caimiao Wei, Ricardo H. Alvarez, Stacy L. Moulder, Aysegul A. Sahin...> ;Oncotarget. 2016 Oct 28
• 230 citations
  Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis.
  Maria Schwaederle, Melissa Zhao, J. Jack Lee, Vladimir Lazar, Brian Leyland-Jones, Richard L. Schilsky, John Mendelsohn, Razelle Kurzrock> ;JAMA Oncology. 2016 Nov 1
• 7 citations
  Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel
  Chan Shen, Funda Meric-Bernstam, Xiaoping Su, John Mendelsohn, Sharon H. Giordano> ;Oncotarget. 2016 Sep 13
• 2 citations
  Commentary on “Recombinant Humanized Anti-HER2 Antibody (Herceptin) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2/neu Overexpressing Human...
  John Mendelsohn> ;Cancer Research. 2016 Sep 15
• 120 citations
  Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol
  Funda Meric-Bernstam, Lauren Brusco, Molly S. Daniels, Chetna Wathoo, Ann Marie Bailey, Louise C. Strong, Kenna Rael Shaw, Karen H. Lu, Yuan Qi, Hao Zhao, Humberto Lar...> ;Annals of Oncology. 2016 May 1
• Response.
  Jardim DL, Schwaederle M, Lee JJ, Wei C, Mendelsohn J, Schilsky RL, Kurzrock R> ;J. Natl. Cancer Inst.. 2016-03-01
• 2 citations
  Reply to M.P. Decatris et al
  Funda Meric-Bernstam, Kenna R. Mills Shaw, John Mendelsohn, Gordon B. Mills> ;Journal of Clinical Oncology. 2016 Jan 11
• 136 citations
  Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval
  Denis Leonardo Fontes Jardim, Maria Schwaederle, Caimiao Wei, J. Jack Lee, David S. Hong, Alexander M.M. Eggermont, Richard L. Schilsky, John Mendelsohn, Vladimir Laza...> ;Journal of the National Cancer Institute. 2015 Nov 1
• 28 citations
  Multigene Clinical Mutational Profiling of Breast Carcinoma Using Next-Generation Sequencing
  Sinchita Roy-Chowdhuri, Debora de Melo Gagliato, Mark J. Routbort, Keyur P. Patel, Rajesh R. Singh, Russell Broaddus, Alexander J. Lazar, Aysegul Sahin, Ricardo H. Alv...> ;American Journal of Clinical Pathology. 2015 Nov 1
• 308 citations
  Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials
  Maria Schwaederle, Melissa Zhao, J. Jack Lee, Alexander M. M. Eggermont, Richard L. Schilsky, John Mendelsohn, Vladimir Lazar, Razelle Kurzrock> ;Journal of Clinical Oncology. 2015 Aug 24
• 52 citations
  Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial
  Jordi Rodon, J-C. Soria, Raanan Berger, Gerald Batist, Apostolia-Maria Tsimberidou, Catherine Bresson, J. Jack Lee, Eitan Rubin, Amir Onn, Richard L. Schilsky, Wilson ...> ;Annals of Oncology. 2015 Aug 1
• 118 citations
  In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
  Ayalew Tefferi, Hagop M. Kantarjian, S. Vincent Rajkumar, Larry Baker, J L Abkowitz, John W. Adamson, Ranjana H. Advani, James P. Allison, Karen H. Antman, Robert C. B...> ;Mayo Clinic Proceedings. 2015 Aug 1
• Join now to see all

Lectures

• Turning the Tide Against Cancer Through Sustained Medical Innovation 
  American Association for Cancer Research, Washington, Dist Of Col - 6/12/2012